CN117794563A - 用于保护以对抗多种血清型的猪链球菌的疫苗 - Google Patents

用于保护以对抗多种血清型的猪链球菌的疫苗 Download PDF

Info

Publication number
CN117794563A
CN117794563A CN202280053633.1A CN202280053633A CN117794563A CN 117794563 A CN117794563 A CN 117794563A CN 202280053633 A CN202280053633 A CN 202280053633A CN 117794563 A CN117794563 A CN 117794563A
Authority
CN
China
Prior art keywords
streptococcus suis
serotype
antigen
igm protease
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280053633.1A
Other languages
English (en)
Chinese (zh)
Inventor
A·A·C·雅各布斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN117794563A publication Critical patent/CN117794563A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/2201—Streptopain (3.4.22.10)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CN202280053633.1A 2021-08-03 2022-06-29 用于保护以对抗多种血清型的猪链球菌的疫苗 Pending CN117794563A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21189283 2021-08-03
EP21189283.1 2021-08-03
PCT/EP2022/067892 WO2023011812A1 (en) 2021-08-03 2022-06-29 A vaccine for protection against streptococcus suis of various serotypes

Publications (1)

Publication Number Publication Date
CN117794563A true CN117794563A (zh) 2024-03-29

Family

ID=77206932

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280053633.1A Pending CN117794563A (zh) 2021-08-03 2022-06-29 用于保护以对抗多种血清型的猪链球菌的疫苗

Country Status (5)

Country Link
US (1) US20240325514A1 (https=)
EP (1) EP4380612A1 (https=)
JP (1) JP2024528169A (https=)
CN (1) CN117794563A (https=)
WO (1) WO2023011812A1 (https=)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201043242A (en) * 2009-03-26 2010-12-16 Intervet Int Bv Vaccine for protection against Streptococcus suis bacteria of various serotypes
WO2013033092A2 (en) * 2011-09-03 2013-03-07 Boehringer Ingelheim Vetmedica Gmbh Streptococcus suis pilus antigens
WO2015181835A1 (en) 2014-05-30 2015-12-03 Naresh Laxminarayan Grover Mobile device with biometric, extra gps and alcohol sensor
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
US11155585B2 (en) 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection
EP3359188A1 (en) * 2015-10-07 2018-08-15 Boehringer Ingelheim Vetmedica, Inc. Streptococcus suis polysaccharide-protein conjugate composition
RU2769573C2 (ru) * 2017-08-03 2022-04-04 Интервет Интернэшнл Б.В. Вакцина для защиты от streptococcus suis
RU2020119271A (ru) 2017-12-15 2022-01-17 Интервет Интернэшнл Б.В. Вакцина для защиты от streptococcus suis
ES3061725T3 (en) 2018-04-03 2026-04-07 Intervet Int Bv A vaccine for protection against streptococcus suis
WO2020094762A1 (en) 2018-11-08 2020-05-14 Intervet International B.V. A vaccine for protection against streptococcus suis
CN112402602A (zh) * 2020-11-09 2021-02-26 山东滨州沃华生物工程有限公司 一种四价猪链球菌病灭活疫苗佐剂、灭活疫苗及制备方法

Also Published As

Publication number Publication date
US20240325514A1 (en) 2024-10-03
JP2024528169A (ja) 2024-07-26
WO2023011812A1 (en) 2023-02-09
EP4380612A1 (en) 2024-06-12

Similar Documents

Publication Publication Date Title
CN104780935B (zh) 减毒猪链球菌疫苗及其制造和使用方法
US11103569B2 (en) Vaccine for protection against Streptococcus suis
JP7571015B2 (ja) 豚レンサ球菌感染防御のためのワクチン
CN115243715B (zh) 保护以对抗血清型9、序列型16的猪链球菌的疫苗
CN112638409B (zh) 组合疫苗
CA2890466A1 (en) Attenuated mannheimia haemolytica vaccines and methods of making and use
CN117794563A (zh) 用于保护以对抗多种血清型的猪链球菌的疫苗
CN117794564A (zh) 用于保护以对抗多种血清型的猪链球菌的疫苗
CN117794565A (zh) 用于保护以对抗多种血清型的猪链球菌的疫苗
RU2841376C1 (ru) Вакцина для защиты от streptococcus suis серотипа 9, тип последовательности 16
RU2802072C2 (ru) Вакцина для защиты от streptococcus suis
HK1203834B (en) Attenuated streptococcus suis vaccines and methods of making and use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination